Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: Role of human organic anion transporters

Drug Metabolism and Disposition

Volumn 38, Issue 7, 2010, Pages 1024-1028

  Leonhardt, Mirko ^a   Keiser, Markus ^a   Oswald, Stefan ^a   Kühn, Jens ^a   Jia, Jia ^a   Grube, Markus ^a   Kroemer, Heyo K ^a   Werner, Siegmund ^a   Werner, Weitschies ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BROMSULFOPHTHALEIN; GADOXETIC ACID; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER P1B1; ORGANIC ANION TRANSPORTER P1B3; ORGANIC ANION TRANSPORTER P2B1; RIFAMPICIN; SODIUM ION; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; CONTRAST MEDIUM; COTRANSPORTER; GADOLINIUM PENTETATE; SODIUM-BILE ACID COTRANSPORTER;

ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CONTRAST ENHANCEMENT; EMBRYO; EMBRYO CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY CELL; LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VECTOR CONTROL; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BINDING COMPETITION; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; ENZYME SPECIFICITY; METABOLISM; PROCEDURES;

BINDING, COMPETITIVE; CELL LINE; CELL SURVIVAL; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RIFAMPIN; SUBSTRATE SPECIFICITY; SULFOBROMOPHTHALEIN; SYMPORTERS; TAUROCHOLIC ACID;

EID: 77953776261     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.032862     Document Type: Article

References (30)

1. Aoki M, Terada T, Ogasawara K, Katsura T, Hatano E, Ikai I, and Inui K (2009) Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. Pharmacogenet Genomics 19:647-656.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Clément O, Mühler A, Vexler V, Berthezène Y, and Brasch RC (1992) Gadoliniumethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 27:612-619.
4. Cui Y, Konig J, Leier I, Buchholz U, and Keppler D (2001) Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626-9630.
5. Grube M, Köck K, Oswald S, Draber K, Meissner K, Eckel L, Böhm M, Felix SB, Vogelgesang S, Jedlitschky G, et al. (2006) Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther 80:607-620.
6. Hagenbuch B and Meier PJ (1994) Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 93:1326-1331. (Pubitemid 24087193)
7. Huang L and Vore M (2001) Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos 29:634-637. (Pubitemid 32374562)
8. Kato N, Yokawa T, Tamura A, Heshiki A, Ebert W, and Weinmann HJ (2002) Gadoliniumethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats. Invest Radiol 37:680-684.
9. Kim RB (2003) Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur J Clin Invest 33 (Suppl 2):1-5.
10. Kim RB, Leake B, Cvetkovic M, Roden MM, Nadeau J, Walubo A, and Wilkinson GR (1999) Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther 291:1204-1209.
11. König J, Cui Y, Nies AT, and Keppler D (2000a) A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 278:G156-G164. (Pubitemid 30108080)
12. König J, Cui Y, Nies AT, and Keppler D (2000b) Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 275:23161-23168.
13. König J, Seithel A, Gradhand U, and Fromm MF (2006) Pharmacogenomics of human OATP transporters. Naunyn Schmiedebergs Arch Pharmacol 372:432-443.
14. Kopplow K, Letschert K, König J, Walter B, and Keppler D (2005) Human hepatobiliary transport of organic anions analyzed by quadruple- transfected cells. Mol Pharmacol 68:1031-1038.
15. Kullak-Ublick GA, Glasa J, Böker C, Oswald M, Grützner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, et al. (1997) Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113:1295-1305.
16. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533.
17. Leslie EM, Watkins PB, Kim RB, and Brouwer KL (2007) Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Ther 321:1170-1178.
18. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, and Stieger B (1997) Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26:1667-1677. (Pubitemid 27520039)
19. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
20. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, and Araki T (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30:1042-1046.
21. Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, and Brasch RC (1992) Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 184:207-213.
22. Muhler A, Oude Elferink RPJ, and Weinmann HJ (1993) Complete elimination of the hepatobiliary mr contrast agent Gd-EOB-DTPA in hepatic dysfunction: an experimental study using transport-deficient, mutant rats. Magnetic Resonance Materials in Physics, Biology and Medicine 1:134-139.
23. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, Taura K, Yasuchika K, Nitta T, Ikai I, et al. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793-798.
24. Schuhmann-Giampieri G, Mahler M, Röll G, Maibauer R, and Schmitz S (1997) Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 37:587-596. (Pubitemid 27443539)
25. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, and Schitt-Willich H [corrected to Schmitt-Willich H] (1993) Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat. J Pharm Sci 82:799-803. (Pubitemid 23314085)
26. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, and Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59-64.
27. Seithel A, Eberl S, Singer K, Auge D, Heinkele G, Wolf NB, Dörje F, Fromm MF, and König J (2007) The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos 35:779-786.
28. Takao H, Akai H, Tajima T, Kiryu S, Watanabe Y, Imamura H, Akahane M, Yoshioka N, Kokudo N, and Ohtomo K (2009) MR imaging of the biliary tract with Gd-EOB-DTPA: Effect of liver function on signal intensity. Eur J Radiol doi: 10.1016/j.ejrad.2009.08.008.
29. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, and Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153-157. (Pubitemid 29302315)
30. Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, and Fattinger K (2002) Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 36:164-172.